Cargando…
CircHIPK3 Promotes Gemcitabine (GEM) Resistance in Pancreatic Cancer Cells by Sponging miR-330-5p and Targets RASSF1
BACKGROUND: Pancreatic cancer is one of the most common malignant diseases in the world. Gemcitabine chemotherapy remains the most important clinical treatment. However, research found that pancreatic cancer cells have chemoresistance to gemcitabine and the effect is not satisfactory. Therefore, it...
Autores principales: | Liu, Yunfei, Xia, Li, Dong, Luo, Wang, Jiale, Xiao, Qiangsheng, Yu, Xiao, Zhu, Hongwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023912/ https://www.ncbi.nlm.nih.gov/pubmed/32104074 http://dx.doi.org/10.2147/CMAR.S239326 |
Ejemplares similares
-
Circular RNA CircHIPK3 Promotes Gemcitabine Sensitivity in Bladder Cancer
por: Xie, Fang, et al.
Publicado: (2020) -
CircHIPK3 Promotes Pyroptosis in Acinar Cells Through Regulation of the miR-193a-5p/GSDMD Axis
por: Wang, Jiale, et al.
Publicado: (2020) -
CircHIPK3 promotes colorectal cancer growth and metastasis by sponging miR-7
por: Zeng, Kaixuan, et al.
Publicado: (2018) -
circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637
por: Zhang, Yanli, et al.
Publicado: (2019) -
circHIPK3 Exacerbates Folic Acid-Induced Renal Tubulointerstitial Fibrosis by Sponging miR-30a
por: Wu, Yan, et al.
Publicado: (2022)